Epitomics an Abcam Company

Epitomics, an Abcam Company, is a biotechnology company based in Burlingame, California. The company employs 32 individuals and generates an annual revenue of $21.4 million. Epitomics specializes in the development of rabbit monoclonal antibody technology (RabMAb) for applications in research, diagnostics, and therapeutics. The company's core offering is its proprietary RabMAb technology, which was invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This innovative platform allows Epitomics to produce high-quality antibodies suitable for a wide range of uses. These antibodies are designed to be valuable tools for researchers, diagnostic laboratories, and pharmaceutical companies. Epitomics differentiates itself through its commitment to developing cutting-edge antibody technologies. The company's RabMAb platform is unique and has the potential to significantly advance research and development in various fields, including the discovery of new drugs and diagnostic tools. For more information about Epitomics and its products, please visit their website at epitomics.com.